We are live on ! Find out more
11A

10-15 Associates Portfolio holdings

AUM $516M Turnover 13.73%
1-Year Est. Return 7.62%
This Fund
S&P 500
This Quarter Est. Return
+13.76%
1 Year Est. Return
+7.62%
3 Year Est. Return
+32.98%
5 Year Est. Return
+79.47%
10 Year Est. Return
–
AUM
$465M
AUM Growth
+$56.7M
Cap. Flow
+$7.41M
Cap. Flow %
1.59%
Top 10 Hldgs %
36.98%
Holding
107
New
15
Increased
33
Reduced
47
Closed
9
Avg Time Held
3 years
Top 10 Avg Time Held
2 years
Top 20 Avg Time Held
2.1 years

Top Buys

Rank Stock Value
1
MPC icon
Marathon Petroleum
MPC
+$10.5M
2
CL icon
Colgate-Palmolive
CL
+$9.92M
3
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$6.95M
4
ZBRA icon
Zebra Technologies
ZBRA
+$2.35M
5
NOBL icon
ProShares S&P 500 Dividend Aristocrats ETF
NOBL
+$2.32M

Top Sells

Rank Stock Value
1
RIO icon
Rio Tinto
RIO
+$10.2M
2
XLNX
Xilinx Inc
XLNX
+$8.52M
3
SLB icon
SLB Ltd
SLB
+$6.72M
4
VGK icon
Vanguard FTSE Europe ETF
VGK
+$2.39M
5
XLF icon
State Street Financial Select Sector SPDR ETF
XLF
+$1.84M

Sector Composition

Rank Sector Weight
1 Healthcare 19.53%
2 Technology 17.58%
3 Financials 11.91%
4 Communication Services 9.61%
5 Consumer Staples 9.43%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
VZ icon
1
Verizon
VZ
$184B
$35.8M 7.7%
605,994
-332
-0.1% -$18.8K
2013 Q2
23 quarters
SBUX icon
2
Starbucks
SBUX
$110B
$17.5M 3.76%
235,368
-5,839
-2% -$401K
2018 Q3
2 quarters
PG icon
3
Procter & Gamble
PG
$365B
$17M 3.65%
163,248
-6,192
-4% -$603K
2015 Q2
15 quarters
JNJ icon
4
Johnson & Johnson
JNJ
$610B
$15.7M 3.37%
112,201
+881
+0.8% +$118K
2013 Q2
23 quarters
INTC icon
5
Intel
INTC
$504B
$15.6M 3.35%
290,342
+10,337
+4% +$524K
2016 Q1
12 quarters
PFE icon
6
Pfizer
PFE
$168B
$14.8M 3.17%
366,320
+4,549
+1% +$182K
2014 Q1
20 quarters
CSCO icon
7
Cisco
CSCO
$433B
$14.7M 3.17%
273,165
-14,181
-5% -$689K
2017 Q3
6 quarters
JPM icon
8
JPMorgan Chase
JPM
$891B
$14M 3.01%
138,271
-239
-0.2% -$24.6K
2013 Q2
23 quarters
MSFT icon
9
Microsoft
MSFT
$4.01T
$13.7M 2.95%
116,449
+4,947
+4% +$540K
2013 Q2
23 quarters
RDS.B
10
DELISTED
Royal Dutch Shell PLC ADS Class B
RDS.B
$13.3M 2.86%
208,285
+7,467
+4% +$472K
2016 Q3
10 quarters
MRK icon
11
Merck
MRK
$358B
$12.9M 2.77%
162,530
+6,376
+4% +$477K
2013 Q4
21 quarters
GSK icon
12
GSK
GSK
$98.2B
$12.8M 2.75%
245,389
+6,923
+3% +$346K
2014 Q4
17 quarters
BA icon
13
Boeing
BA
$149B
$12.6M 2.7%
32,938
-586
-2% -$226K
2013 Q2
23 quarters
ELV icon
14
Elevance Health
ELV
$92.9B
$12.4M 2.67%
43,257
+480
+1% +$139K
2018 Q3
2 quarters
GIS icon
15
General Mills
GIS
$17.6B
$12.4M 2.66%
239,688
+5,278
+2% +$239K
2018 Q2
3 quarters
XLNX
16
DELISTED
Xilinx Inc
XLNX
$12.3M 2.64%
97,053
-75,865
-44% -$8.52M
2018 Q3
2 quarters
ACN icon
17
Accenture
ACN
$138B
$11.3M 2.44%
64,445
+3,785
+6% +$595K
2018 Q4
1 quarter
ABBV icon
18
AbbVie
ABBV
$501B
$11.3M 2.43%
140,370
+8,471
+6% +$693K
2015 Q1
16 quarters
CB icon
19
Chubb
CB
$136B
$11M 2.36%
78,340
+2,480
+3% +$330K
2018 Q3
2 quarters
UPS icon
20
United Parcel Service
UPS
$83.2B
$10.9M 2.33%
97,235
+2,908
+3% +$308K
2018 Q1
4 quarters
KKR icon
21
KKR & Co
KKR
$78.7B
$10.7M 2.29%
454,688
+14,881
+3% +$339K
2015 Q1
16 quarters
CL icon
22
Colgate-Palmolive
CL
$73.9B
$10.5M 2.26%
+153,638
New +$9.92M
2019 Q1
0 quarters
PNC icon
23
PNC Financial Services
PNC
$85.7B
$10.5M 2.25%
85,515
-993
-1% -$123K
2013 Q4
21 quarters
EPD icon
24
Enterprise Products Partners
EPD
$76.8B
$10.1M 2.17%
347,758
+4,144
+1% +$116K
2013 Q2
23 quarters
MPC icon
25
Marathon Petroleum
MPC
$134B
$10M 2.15%
+167,490
New +$10.5M
2019 Q1
0 quarters
1
2 3 4 5

Similar funds

IA
Independence Advisors Wayne, Pennsylvania $466M AUM 11.32% 1-Year Est. Return
CPF
Context Partners Fund La Jolla, California $460M AUM
AIM
AIA Investment Management Singapore $437M AUM 64.44% 1-Year Est. Return
VCP
Vestar Capital Partners New York $435M AUM 20.18% 1-Year Est. Return
LWS
Lucia Wealth Services San Diego, California $426M AUM 19.43% 1-Year Est. Return
FA
FCG Advisors Chatham, New Jersey $425M AUM 12.09% 1-Year Est. Return
CCM
Cadence Capital Management Boston, Massachusetts $415M AUM 11.01% 1-Year Est. Return
KFA
Kays Financial Advisory Atlanta, Georgia $624M AUM 9.93% 1-Year Est. Return

10-15 Associates's Q1 2019 Portfolio in Review

As of Q1 2019, 10-15 Associates held 107 positions worth $465M, up 14% from $409M the previous quarter. Its ten largest holdings account for 37% of the portfolio.

10-15 Associates's Q1 2019 filing shows 15 new, 33 increased, 47 reduced and 9 closed positions. Its largest new stake was Marathon Petroleum: 167,490 shares worth $10M. The largest sale was Rio Tinto, an estimated $10.2M.

By sector, the portfolio is most concentrated in Healthcare at 20% of assets, down from 21% a quarter earlier, followed by Technology and Financials.

  • 10-15 Associates's largest Q1 2019 buy was Marathon Petroleum: 167,490 shares worth $10M.
  • 10-15 Associates added most to ProShares S&P 500 Dividend Aristocrats ETF in Q1 2019, an estimated $2.32M increase.
  • 10-15 Associates's biggest Q1 2019 reduction was Xilinx Inc, cutting an estimated $8.52M.
  • 10-15 Associates fully exited Rio Tinto in Q1 2019, selling an estimated $10.2M.
  • 10-15 Associates's ten largest holdings make up 37% of its $465M portfolio in Q1 2019.
  • 10-15 Associates opened 15 new positions and closed 9 in Q1 2019.
  • 10-15 Associates's portfolio value rose 14% quarter-over-quarter to $465M.

Based on 10-15 Associates's 13F filing for Q1 2019, filed 9 May 2019.